Semmax Financial Advisors »

Acurx Pharmaceuticals shares owned by Semmax Financial Advisors

Quarter-by-quarter ownership of Acurx Pharmaceuticals shares owned by Semmax Financial Advisors from 13F filings

Historical chart of Semmax Financial Advisors investment in Acurx Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Acurx Pharmaceuticals held by Semmax Financial Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Acurx Pharmaceuticals by Semmax Financial Advisors

Quarter filed Position value Share count Share price at filing
2025-06-30 $684 153 4.47
2025-03-31 $2.0k 5.6k 0.36
2024-09-30 $11k 5.9k 1.85
2024-06-30 $11k 5.9k 1.90
2024-03-31 $12k 5.9k 2.09
2023-12-31 $17k 5.9k 2.80
2023-09-30 $21k 5.9k 3.50
2022-12-31 $24k 5.9k 4.08
2022-09-30 $17k 5.9k 2.89
2022-06-30 $28k 5.9k 4.76
2022-03-31 $4.0k 1.3k 3.17
2021-12-31 $5.0k 1.3k 3.96
2021-09-30 $6.0k 1.3k 4.75

More positions owned by Semmax Financial Advisors

Ishares Tr Fltg Rate Nt Etf (FLOT)
Vanguard Index Fds Growth Etf (VUG)
JPMorgan Chase & Co. (JPM)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Janus Detroit Str Tr Hendrson Aaa Cl (JAAA)
Ishares U S Etf Tr Short Duration B (NEAR)
Microsoft Corporation (MSFT)
Vanguard Index Fds Value Etf (VTV)
Meta Platforms Cl A (META)
Exxon Mobil Corporation (XOM)
Tidal Trust I Foliobeyond Alte (RISR)
Ishares Tr Tips Bd Etf (TIP)
Booking Holdings (BKNG)
Wells Fargo & Company (WFC)
Enbridge (ENB)

View all positions for Semmax Financial Advisors

Top funds holding Acurx Pharmaceuticals

Morgan Stanley
Advisor Group Holdings
Semmax Financial Advisors

View all funds holding Acurx Pharmaceuticals